Researchers discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, simulations, ...

"Emerging Fusion Protein Technologies Drive Innovation in Targeted Therapies Across Autoimmune, Cancer, Metabolic, and ...

Washington State University researchers have found a way to modulate a common virus protein to prevent viruses from entering ...

Washington State University researchers are using AI and simulations to pinpoint a single molecular interaction that blocks ...

Washington State University researchers have found a way to modulate a common virus protein to prevent viruses from entering ...

A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...

Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they ...

Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...

Vor Bio intends to use the net proceeds from the private placement to advance the clinical development of telitacicept, including the ongoing global Phase 3 clinical trial for myasthenia gravis and ...

The novel drug atacicept was associated with significant reductions in proteinuria vs. placebo with comparable safety and no ...

Integrated analytical workflows are transforming cell line development by combining faster screening and streamlined decision-making.

In addition, Vera Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 920,716 shares of Class A common stock at the public offering price, less underwriting ...